Hyperlipidaemia and Eustachian tube obstruction

Summary:

Eustachian tube obstruction is found among people with Hyperlipidaemia, especially for people who are female, 60+ old.

The study analyzes which people have Eustachian tube obstruction with Hyperlipidaemia. It is created by eHealthMe based on reports of 12 people who have Hyperlipidaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,420 drugs and 1,410 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

What is Eustachian tube obstruction?

Eustachian tube obstruction (blockage of the eustachian tube) is found to be associated with 31 drugs and 135 conditions by eHealthMe. Check the latest studies of Eustachian tube obstruction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

12 people who have Hyperlipidaemia and Eustachian Tube Obstruction are studied.

Would you have Eustachian tube obstruction when you have Hyperlipidaemia?

Gender of people who have Hyperlipidaemia and experienced Eustachian Tube Obstruction *:

female: 66.67 %
male: 33.33 %

Age of people who have Hyperlipidaemia and experienced Eustachian Tube Obstruction *:

Common co-existing conditions for these people *:

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 66.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 33.33%
High Blood Cholesterol: 2 people, 16.67%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 16.67%
Essential Hypertension (primary hypertension): 2 people, 16.67%
Diabetes: 2 people, 16.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 16.67%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%

Common drugs taken by these people *:

Common symptoms for these people *:

Pain: 8 people, 66.67%
Hypoacusis (loss of hearing): 7 people, 58.33%
Dizziness: 7 people, 58.33%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 50.00%
Chest Pain: 6 people, 50.00%
Weight Loss: 5 people, 41.67%
Hair Loss: 5 people, 41.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 41.67%
Hyperkeratosis (thickening of the outer layer of the skin): 5 people, 41.67%
High Blood Pressure: 5 people, 41.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Eustachian tube obstruction?

- Check whether Eustachian tube obstruction is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Eustachian tube obstruction and Hyperlipidaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.